Position
Chief Operating Officer
Company
Haya Therapeutics
LausanneBiotechnologyHealth CareScience And EngineeringDescription
HAYA Therapeutics, SA announced that Eric Adam, Ph.D. has joined as Chief Operating Officer (COO). With over 25 years of experience in health technology and healthcare sectors, Eric joins HAYA’s team in Lausanne after serving as Global Head of Operations within Neuroscience and Rare Diseases in Pharma Research and Early Development (pRED) at Roche.
Quick answer
HAYA Therapeutics Names Eric Adam as Chief Operating Officer (July 18, 2024). Haya Therapeutics is based in Lausanne, Vaud, Switzerland.
- Who is the new Chief Operating Officer at Haya Therapeutics?
- Haya Therapeutics named Eric Adam Chief Operating Officer, announced July 18, 2024.
- What did Haya Therapeutics announce on July 18, 2024?
- HAYA Therapeutics, SA announced that Eric Adam, Ph.D. has joined as Chief Operating Officer (COO). With over 25 years of experience in health technology and healthcare sectors, Eric joins HAYA’s team in Lausanne after serving as Global Head of Operations within Neuroscience and Rare Diseases in Pharma Research and Early Development (pRED) at Roche.
- What does Haya Therapeutics do?
- HAYA Therapeutics is a precision medicines company developing programmable therapeutics targeting regulatory RNAs derived from the dark genome, a cell information processing unit, to reprogram pathological cell states...
- Where is Haya Therapeutics based?
- Haya Therapeutics is based in Lausanne, Vaud, Switzerland.
- Which similar companies made leadership changes around the same time?
- Moma Therapeutics (June 25, 2024), Atavistik Bio (August 12, 2024), Exscientia (June 6, 2024) and Electra Therapeutics (August 29, 2024) also announced leadership changes within 45 days of Haya Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- MOMA Therapeutics Appoints Marc Ballas as SVP, Head of Clinical Development, and Adam Thomas as Chief People and Experience Officer (June 25, 2024)
- Atavistik Bio Appoints Paul Bruno, Ph.D. as Chief Business Officer (August 12, 2024)
- Exscientia Appoints John P. Overington as Chief Technology Officer and Marie-Louise Fjällskog, M.D., Ph.D., as Interim Chief Medical Officer (June 6, 2024)
- Electrasteel Inc. Appoints James Rutland as Chief Financial Officer and Steve MacManus as Vice President of Engineering (August 29, 2024)
- Lixte Biotechnology Holdings Appoints Dr. Jan Schellens as Chief Medical Officer (June 5, 2024)
- BeiGene Appoints Aaron Rosenberg as Chief Financial Officer (July 18, 2024)
Who to call at Haya Therapeutics, and when
A new leader at Haya Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Haya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Haya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Haya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Haya Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Haya Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.